Proteomics study of the antifibrotic effects of α-mangostin in a rat model of renal fibrosis

[1]Neild GH. Life expectancy with chronic kidney disease: an educational review. Pediatr Nephrol. 2017; 32:243–8.NeildGHLife expectancy with chronic kidney disease: an educational reviewPediatr Nephrol201732243810.1007/s00467-016-3383-8Search in Google Scholar

[2]Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR. Chronic kidney disease and life expectancy. Nephrol Dial Transplant. 2012; 27:3182–6.TurinTCTonelliMMannsBJRavaniPAhmedSBHemmelgarnBRChronic kidney disease and life expectancyNephrol Dial Transplant2012273182610.1093/ndt/gfs052Search in Google Scholar

[3]Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. Clin J Am Soc Nephrol. 2004; 15:1–12.LiuYEpithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic interventionClin J Am Soc Nephrol20041511210.1097/01.ASN.0000106015.29070.E7Search in Google Scholar

[4]Singh NP, Ganguli A, Prakash A. Drug-induced kidney diseases. J Assoc Physicians India. 2003; 51:970–9.SinghNPGanguliAPrakashADrug-induced kidney diseasesJ Assoc Physicians India2003519709Search in Google Scholar

[5]Taal M, Brenner B. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006; 70:1694–705.TaalMBrennerBPredicting initiation and progression of chronic kidney disease: developing renal risk scoresKidney Int200670169470510.1038/sj.ki.5001794Search in Google Scholar

[6]Collins AJ, Foley RN, Gilbertson DT, Chen S-C. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl. 2015; 5:2–7.CollinsAJFoleyRNGilbertsonDTChenS-CUnited States Renal Data System public health surveillance of chronic kidney disease and end-stage renal diseaseKidney Int Suppl201552710.1038/kisup.2015.2Search in Google Scholar

[7]Klinkhammer BM, Goldschmeding R, Floege J, Boor P. Treatment of renal fibrosis—turning challenges into opportunities. Adv Chronic Kidney Dis. 2017; 24:117–29.KlinkhammerBMGoldschmedingRFloegeJBoorPTreatment of renal fibrosis—turning challenges into opportunitiesAdv Chronic Kidney Dis2017241172910.1053/j.ackd.2016.11.002Search in Google Scholar

[8]El Nahas A, Muchaneta-Kubara E, Essaway M, Soylemezoglu O. Renal fibrosis: insights into pathogenesis and treatment. Int J Biochem Cell Biol. 1997; 29:55–62.ElNahas AMuchaneta-KubaraEEssawayMSoylemezogluORenal fibrosis: insights into pathogenesis and treatmentInt J Biochem Cell Biol199729556210.1016/S1357-2725(96)00119-7Search in Google Scholar

[9]Ibrahim MY, Hashim NM, Mariod AA, Mohan S, Mahmood AA, Arbab IA. α-Mangostin from Garcinia mangostana Linn: an updated review of its pharmacological properties. Arab J Chem. 2016; 9:317–29.IbrahimMYHashimNMMariodAAMohanSMahmoodAAArbabIAα-Mangostin from Garcinia mangostana Linn: an updated review of its pharmacological propertiesArab J Chem201693172910.1016/j.arabjc.2014.02.011Search in Google Scholar

[10]Govindachari T, Kalyanaraman P, Muthukumaraswamy N, Pai B. Xanthones of Garcinia mangostana Linn. Tetrahedron. 1971; 27:3919–26.GovindachariTKalyanaramanPMuthukumaraswamyNPaiBXanthones of Garcinia mangostana LinnTetrahedron19712739192610.1016/S0040-4020(01)98253-5Search in Google Scholar

[11]Poonkhum R, Watanapokasin R, Pradidarcheep W. Protective effect of alpha-mangostin against type-I collagen formation in thioacetamide-induced cirrhotic rat. J Med Assoc Thai. 2012; 95:S93–8.PoonkhumRWatanapokasinRPradidarcheepWProtective effect of alpha-mangostin against type-I collagen formation in thioacetamide-induced cirrhotic ratJ Med Assoc Thai201295S938Search in Google Scholar

[12]Martínez-Abundis E, García N, Correa F, Hernández-Reséndiz S, Pedraza-Chaverri J, Zazueta C. Effects of α-mangostin on mitochondrial energetic metabolism. Mitochondrion. 2010; 10:151–7.Martínez-AbundisEGarcíaNCorreaFHernández-ReséndizSPedraza-ChaverriJZazuetaCEffects of α-mangostin on mitochondrial energetic metabolismMitochondrion201010151710.1016/j.mito.2009.12.14020005989Search in Google Scholar

[13]Mas VR, Fisher RA, Archer KJ, Maluf DG. Proteomics and liver fibrosis: identifying markers of fibrogenesis. Expert Rev Proteomics. 2009; 6:421–31.MasVRFisherRAArcherKJMalufDGProteomics and liver fibrosis: identifying markers of fibrogenesisExpert Rev Proteomics200964213110.1586/epr.09.59Search in Google Scholar

[14]Moongkarndi P, Jaisupa N, Samer J, Kosem N, Konlata J, Rodpai E, Pongpan N. Comparison of the biological activity of two different isolates from mangosteen. J Pharm Pharmacol. 2014; 66:1171–79.MoongkarndiPJaisupaNSamerJKosemNKonlataJRodpaiEPongpanNComparison of the biological activity of two different isolates from mangosteenJ Pharm Pharmacol20146611717910.1111/jphp.12239Search in Google Scholar

[15]Junqueira LCU, Bignolas G, Brentani R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979; 11:447–55.JunqueiraLCUBignolasGBrentaniRPicrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sectionsHistochem J1979114475510.1007/BF01002772Search in Google Scholar

[16]Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9:671–5.SchneiderCARasbandWSEliceiriKWNIH Image to ImageJ: 25 years of image analysisNat Methods20129671510.1038/nmeth.2089Search in Google Scholar

[17]Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265–75.LowryOHRosebroughNJFarrALRandallRJProtein measurement with the Folin phenol reagentJ Biol Chem19511932657510.1016/S0021-9258(19)52451-6Search in Google Scholar

[18]Blum H, Beier H, Gross HJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis. 1987; 8:93–9.BlumHBeierHGrossHJImproved silver staining of plant proteins, RNA and DNA in polyacrylamide gelsElectrophoresis1987893910.1002/elps.1150080203Search in Google Scholar

[19]Jaresitthikunchai J, Phaonakrop N, Kittisenachai S, Roytrakul S. Rapid in-gel digestion protocol for protein identification by peptide mass fingerprint. Proceedings of the 2nd Biochemistry and Molecular Biology Conference: Biochemistry and Molecular Biology for Regional Sustainable Development. 2009 May 7–8, Khon Kaen, Thailand. p. 29.JaresitthikunchaiJPhaonakropNKittisenachaiSRoytrakulSRapid in-gel digestion protocol for protein identification by peptide mass fingerprintProceedings of the 2nd Biochemistry and Molecular Biology Conference: Biochemistry and Molecular Biology for Regional Sustainable Development2009May7–8Khon Kaen, Thailandp29Search in Google Scholar

[20]Johansson C, Samskog J, Sundström L, Wadensten H, Björkesten L, Flensburg J. Differential expression analysis of Escherichia coli proteins using a novel software for relative quantitation of LC - MS/ MS data. Proteomics. 2006; 6:4475–85.JohanssonCSamskogJSundströmLWadenstenHBjörkestenLFlensburgJDifferential expression analysis of Escherichia coli proteins using a novel software for relative quantitation of LC - MS/ MS dataProteomics2006644758510.1002/pmic.20050092116858737Search in Google Scholar

[21]Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011; 39(Database issue):D561–8.SzklarczykDFranceschiniAKuhnMSimonovicMRothAMinguezPet alThe STRING database in 2011 functional interaction networks of proteins, globally integrated and scoredNucleic Acids Res201139Database issueD561810.1093/nar/gkq973301380721045058Search in Google Scholar

[22]Barker EA, Smuckler EA. Nonhepatic thioacetamide injury: II. The morphologic features of proximal renal tubular injury. Am J Pathol. 1974; 74:575.BarkerEASmucklerEANonhepatic thioacetamide injury: II. The morphologic features of proximal renal tubular injuryAm J Pathol197474575Search in Google Scholar

[23]Ghosh S, Sarkar A, Bhattacharyya S, Sil PC. Silymarin protects mouse liver and kidney from thioacetamide induced toxicity by scavenging reactive oxygen species and activating PI3K-Akt pathway. Front Pharmacol. 2016; 7:481. doi: 10.3389/ fphar.2016.00481.GhoshSSarkarABhattacharyyaSSilPCSilymarin protects mouse liver and kidney from thioacetamide induced toxicity by scavenging reactive oxygen species and activating PI3K-Akt pathwayFront Pharmacol2016748110.3389/ fphar.2016.00481Open DOISearch in Google Scholar

[24]Adler SG, Schwartz S, Williams ME, Arauz-Pacheco C, Bolton WK, Lee T, et al. Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol. 2010; 5:1420–8.AdlerSGSchwartzSWilliamsMEArauz-PachecoCBoltonWKLeeTet alPhase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuriaClin J Am Soc Nephrol201051420810.2215/CJN.09321209292440520522536Search in Google Scholar

[25]Pérez-Rojas JM, Cruz C, García-López P, Sánchez-González DJ, Martínez-Martínez CM, Ceballos G, et al. Renoprotection by α-mangostin is related to the attenuation in renal oxidative/ nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res. 2009; 43:1122–32.Pérez-RojasJMCruzCGarcía-LópezPSánchez-GonzálezDJMartínez-MartínezCMCeballosGet alRenoprotection by α-mangostin is related to the attenuation in renal oxidative/ nitrosative stress induced by cisplatin nephrotoxicityFree Radic Res20094311223210.1080/1071576090321444719863372Search in Google Scholar

[26]Devi Sampath P, Vijayaraghavan K. Cardioprotective effect of α-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol. 2007; 21:336–9.DeviSampath PVijayaraghavanKCardioprotective effect of α-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in ratsJ Biochem Mol Toxicol200721336910.1002/jbt.2019917994576Search in Google Scholar

[27]Sato A, Fujiwara H, Oku H, Ishiguro K, Ohizumi Y. α-Mangostin induces Ca²⁺-ATPase-dependent apoptosis via mitochondrial pathway in PC12 cells. Am J Pharmacol Sci. 2004; 95:33–40.SatoAFujiwaraHOkuHIshiguroKOhizumiYα-Mangostin induces Ca²⁺-ATPase-dependent apoptosis via mitochondrial pathway in PC12 cellsAm J Pharmacol Sci200495334010.1254/jphs.95.3315153648Search in Google Scholar

[28]Safa A. c-FLIP, a master anti-apoptotic regulator. Exp Oncol. 2012; 34:176–84.SafaAc-FLIP a master anti-apoptotic regulatorExp Oncol20123417684Search in Google Scholar

[29]Haag C, Stadel D, Zhou S, Bachem MG, Möller P, Debatin KM, Fulda S. Identification of c-FLIP_L and c-FLIP_S as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells. Gut. 2011; 60:225–37.HaagCStadelDZhouSBachemMGMöllerPDebatinKMFuldaSIdentification of c-FLIP_L and c-FLIP_S as critical regulators of death receptor-induced apoptosis in pancreatic cancer cellsGut2011602253710.1136/gut.2009.20232520876774Search in Google Scholar

[30]Safa AR, Day TW, Wu C-H. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets. 2008; 8:37–46.SafaARDayTWWuC-HCellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapyCurr Cancer Drug Targets20088374610.2174/156800908783497087452451018288942Search in Google Scholar

[31]Borrelli S, Candi E, Alotto D, Castagnoli C, Melino G, Viganò MA, Mantovani R. p63 regulates the caspase-8-FLIP apoptotic pathway in epidermis. Cell Death Differ. 2009; 16:253–63.BorrelliSCandiEAlottoDCastagnoliCMelinoGViganòMAMantovaniRp63 regulates the caspase-8-FLIP apoptotic pathway in epidermisCell Death Differ2009162536310.1038/cdd.2008.14718927586Search in Google Scholar

[32]Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science. 1998; 281(5383):1668–71.SchaefferHJCatlingADEblenSTCollierLSKraussAWeberMJMP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascadeScience1998281538316687110.1126/science.281.5383.16689733512Search in Google Scholar

[33]Jun S, Lee S, Kim H-C, Ng C, Schneider AM, Ji H, et al. PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. Cell Rep. 2013; 5:314–22.JunSLeeSKimH-CNgCSchneiderAMJiHet alPAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesisCell Rep201353142210.1016/j.celrep.2013.09.026415735324209743Search in Google Scholar

[34]Ma FY, Sachchithananthan M, Flanc RS, Nikolic-Paterson DJ. Mitogen activated protein kinases in renal fibrosis. Front Biosci (Schol Ed). 2009; 1:171–87.MaFYSachchithananthanMFlancRSNikolic-PatersonDJMitogen activated protein kinases in renal fibrosisFront Biosci (Schol Ed)200911718710.2741/s1719482693Search in Google Scholar

[35]Banas B, Wörnle M, Berger T, Nelson PJ, Cohen CD, Kretzler M, et al. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol. 2002; 168:4301–7.BanasBWörnleMBergerTNelsonPJCohenCDKretzlerMet alRoles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasisJ Immunol20021684301710.4049/jimmunol.168.9.430111970971Search in Google Scholar

[36]Zhang H, Sun S-C. NF-κB in inflammation and renal diseases. Cell Biosci. 2015; 5:63. doi: 10.1186/s13578-015-0056-4ZhangHSunS-CNF-κB in inflammation and renal diseasesCell Biosci201556310.1186/s13578-015-0056-4464771026579219Open DOISearch in Google Scholar

[37]Zhang X, Wang Y, Mao Z, Huang D, Zhou J, Wang X. Expression of NF-kB-inducing kinase in breast carcinoma tissue and its clinical significance. Int J Clin Exp Pathol. 2015; 8:14824–9.ZhangXWangYMaoZHuangDZhouJWangXExpression of NF-kB-inducing kinase in breast carcinoma tissue and its clinical significanceInt J Clin Exp Pathol20158148249Search in Google Scholar

[38]Choudhary S, Kalita M, Fang L, Patel KV, Tian B, Zhao Y, et al. Inducible tumor necrosis factor (TNF) receptor-associated factor-1 expression couples the canonical to the non-canonical NF-κB pathway in TNF stimulation. J Biol Chem. 2013; 288: 14612–23.ChoudharySKalitaMFangLPatelKVTianBZhaoYet alInducible tumor necrosis factor (TNF) receptor-associated factor-1 expression couples the canonical to the non-canonical NF-κB pathway in TNF stimulationJ Biol Chem2013288146122310.1074/jbc.M113.464081365631323543740Search in Google Scholar

[39]Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, et al. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol Cell Biol. 1999; 19:7539–48.ItoMYoshiokaKAkechiMYamashitaSTakamatsuNSugiyamaKet alJSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathwayMol Cell Biol19991975394810.1128/MCB.19.11.75398476310523642Search in Google Scholar

[40]Grynberg K, Ma FY, Nikolic-Paterson DJ. The JNK signaling pathway in renal fibrosis. Front Physiol. 2017; 8:829. doi: 10.3389/fphys.2017.00829GrynbergKMaFYNikolic-PatersonDJThe JNK signaling pathway in renal fibrosisFront Physiol2017882910.3389/fphys.2017.00829566069729114233Open DOISearch in Google Scholar

[41]Dhanasekaran D, Kashef K, Lee C, Xu H, Reddy E. Scaffold proteins of MAP-kinase modules. Oncogene. 2007; 26:3185–202.DhanasekaranDKashefKLeeCXuHReddyEScaffold proteins of MAP-kinase modulesOncogene200726318520210.1038/sj.onc.121041117496915Search in Google Scholar

[42]Takino T, Nakada M, Miyamori H, Watanabe Y, Sato T, Gantulga D, et al. JSAP1/JIP3 cooperates with focal adhesion kinase to regulate c-Jun N-terminal kinase and cell migration. J Biol Chem. 2005; 280:37772–81.TakinoTNakadaMMiyamoriHWatanabeYSatoTGantulgaDet alJSAP1/JIP3 cooperates with focal adhesion kinase to regulate c-Jun N-terminal kinase and cell migrationJ Biol Chem2005280377728110.1074/jbc.M50524120016141199Search in Google Scholar

[43]Lagares D, Kapoor M. Targeting focal adhesion kinase in fibrotic diseases. BioDrugs. 2013; 27:15–23.LagaresDKapoorMTargeting focal adhesion kinase in fibrotic diseasesBioDrugs201327152310.1007/s40259-012-0003-423329396Search in Google Scholar